Publicacions (34) Publicacions de María Del Carmen García Macías

2024

  1. RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade

    Nature Communications, Vol. 15, Núm. 1

  2. Unmutated RRAS2 emerges as a key oncogene in post-partum-associated triple negative breast cancer

    Molecular Cancer, Vol. 23, Núm. 1

2023

  1. Effects of Dietary Supplementation with a Ferulic Acid-Rich Bioactive Component of Wheat Bran in a Murine Model of Graft-Versus-Host Disease

    Nutrients, Vol. 15, Núm. 21

  2. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

2022

  1. A hotspot mutation targeting the R-RAS2 GTPase acts as a potent oncogenic driver in a wide spectrum of tumors

    Cell Reports, Vol. 38, Núm. 11

  2. Mesenchymal Stromal Cells Combined With Elastin-Like Recombinamers Increase Angiogenesis In Vivo After Hindlimb Ischemia

    Frontiers in Bioengineering and Biotechnology, Vol. 10

  3. Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia

    Molecular Cancer, Vol. 21, Núm. 1

2021

  1. Granuloma formation in a cyba-deficient model of chronic granulomatous disease is associated with myeloid hyperplasia and the exhaustion of B-cell lineage

    International Journal of Molecular Sciences, Vol. 22, Núm. 16

2020

  1. Pathophysiological mechanisms underlying a rat model of triple whammy acute kidney injury

    Laboratory Investigation, Vol. 100, Núm. 11, pp. 1455-1464

  2. VAV2 signaling promotes regenerative proliferation in both cutaneous and head and neck squamous cell carcinoma

    Nature Communications, Vol. 11, Núm. 1

  3. Vav2 pharmaco-mimetic mice reveal the therapeutic value and caveats of the catalytic inactivation of a Rho exchange factor

    Oncogene, Vol. 39, Núm. 28, pp. 5098-5111

2017

  1. Correction: The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin [Oncotarget, 6, (2015), (18875-18890)]. doi: 10.18632/oncotarget.4303

    Oncotarget

2015

  1. Immunosuppression-Independent Role of Regulatory T Cells against Hypertension-Driven Renal Dysfunctions

    Molecular and Cellular Biology, Vol. 35, Núm. 20, pp. 3528-3546

2014

  1. Enhancement of conventional TBNA outcome after EBUS training

    Journal of Bronchology and Interventional Pulmonology, Vol. 21, Núm. 4, pp. 322-326

2012

  1. Immunophenotypic identification and characterization of tumor cells and infiltrating cell populations in meningiomas

    American Journal of Pathology, Vol. 181, Núm. 5, pp. 1749-1761

  2. Incidencia de recurrencia axilar tras un ganglio centinela negativo en cáncer de mama en estadios iniciales: Seguimiento de 5 años

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 31, Núm. 4, pp. 173-177

  3. Soft tissue myoepithelial carcinoma without EWSR1 gene rearrangement and poor outcome. A case report

    Revista Espanola de Patologia, Vol. 45, Núm. 1, pp. 58-63

2011

  1. Prevalence of human papillomavirus genotypes in cytologic abnormalities from unvaccinated women living in north-western Spain

    APMIS, Vol. 119, Núm. 3, pp. 204-215

2008

  1. La biopsia del ganglio centinela en cáncer de mama de más de 3 cm y axila clínicamente negativa frente a la indicación estándar T1-T2 < 3 cm

    Revista Espanola de Medicina Nuclear, Vol. 27, Núm. 3, pp. 176-182

  2. Phosphoinositide 3-kinase/AKT signaling can promote AIB1 stability independently of GSK3 phosphorylation

    Cancer Research, Vol. 68, Núm. 13, pp. 5450-5459